"Despite induction failure being 3-times more common in T-ALL than B-ALL, little was known about risk factors, optimum treatment, and the genomic landscape. If we can gain more understanding, we hope ...
Quality of Life Among Long-Term Survivors of Non-Hodgkin Lymphoma: A Follow-Up Study Four hundred thirty-eight patients received EMA/CO between 1995 and 2010. Six patients had nGTTs, 140 had high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results